Cite
Concurrent chemoradiotherapy versus radiotherapy alone after induction chemoimmunotherapy for stage III NSCLC patients who did not undergo surgery: a single institution retrospective study.
MLA
Guan, Song, et al. “Concurrent Chemoradiotherapy versus Radiotherapy Alone after Induction Chemoimmunotherapy for Stage III NSCLC Patients Who Did Not Undergo Surgery: A Single Institution Retrospective Study.” Radiation Oncology, vol. 18, no. 1, July 2023, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s13014-023-02305-5.
APA
Guan, S., Ren, K., Zhang, X., Yan, M., Li, X., & Zhao, L. (2023). Concurrent chemoradiotherapy versus radiotherapy alone after induction chemoimmunotherapy for stage III NSCLC patients who did not undergo surgery: a single institution retrospective study. Radiation Oncology, 18(1), 1–8. https://doi.org/10.1186/s13014-023-02305-5
Chicago
Guan, Song, Kai Ren, Xuyu Zhang, Meng Yan, Xue Li, and Lujun Zhao. 2023. “Concurrent Chemoradiotherapy versus Radiotherapy Alone after Induction Chemoimmunotherapy for Stage III NSCLC Patients Who Did Not Undergo Surgery: A Single Institution Retrospective Study.” Radiation Oncology 18 (1): 1–8. doi:10.1186/s13014-023-02305-5.